SPDR Dow Jones Industrial Average ETF

SPDR S&P 500 ETF Trust

Invesco QQQ Trust Series 1

SELLAS Life Sciences Group, Inc. is a clinical stage biopharmaceutical company, which engages in the development and commercialization of immunotherapeutic for cancer indications. Its product pipeline includes galinpepimut-S. The company was founded by Angelos M. Stergiou on April 3, 2006 and is headquartered in New York, NY.

SELLAS Life Sciences Group Inc

SELLAS Life Sciences is trending as retail investors await an imminent phase 3 data readout, fueled by speculation that an upcoming media appearance by the CEO will signal a major milestone or potential buyout. The community remains deeply divided, with bulls pointing to survival data and institutional accumulation as evidence of a breakthrough, while bears cite historical clinical trial failure risks and concerns over trial design.

Ondas, Inc. engages in the development, marketing, and sale of wireless radio systems for secure, wide area mission-critical business-to-business networks. It operates through the Ondas Networks and Ondas Autonomous Systems segments. The Ondas Networks segment provides wireless connectivity solutions enabling mission-critical Industrial Internet applications and services. The Ondas Autonomous Systems segment designs, develops, and markets commercial drone solutions via the Optimus System and Scout System. The company was founded on December 22, 2014 and is headquartered in West Palm Beach, FL.

Ondas Inc.

Ondas Inc

Ondas Inc. is seeing intense volatility and record-breaking trading volume as investors debate whether current levels represent a massive accumulation opportunity or a continued downtrend following recent acquisitions and dilution concerns. The community is heavily focused on the company's defense-tech narrative and upcoming executive meetings, while sentiment remains deeply polarized between those betting on long-term autonomous drone adoption and those skeptical of current execution and management strategy.

Polkadot is a platform that allows diverse blockchains to transfer messages, including value, in a trust-free fashion; sharing their unique features while pooling their security. In brief, Polkadot is a scalable heterogeneous multi-chain technology.  Polkadot is heterogeneous because it is entirely flexible and makes no assumption about the nature or structure of the chains in the network. Even non-blockchain systems or data structures can become parachains if they fulfill a set of criteria.  Polkadot may be considered equivalent to a set of independent chains (e.g. a set containing Ethereum, Ethereum Classic, Namecoin and Bitcoin) except with important additions: pooled security and trust-free interchain transactability.  Many of the native parachains of Polkadot will be written using a Polkadot Runtime Environment SDK (e.g. Parity Technologies' Substrate).

Polkadot

Polkadot is facing significant community polarization as investors debate whether the recent shift to a capped tokenomics model and upgraded infrastructure will trigger a long-term recovery or if the persistent downtrend indicates a failed project. While some holders are actively accumulating to average down, citing institutional interest and upcoming network upgrades, many vocal participants remain skeptical, pointing to lackluster price performance compared to the broader market and aggressive liquidations.

ImmunityBio, Inc. is a clinical stage immunotherapy company. It develops next generation therapies that drive immunogenic mechanisms for defeating cancers and infectious diseases. The company's immunotherapy platform activates both the innate and adaptive immune systems to create long term immunological memory. ImmunityBio was founded by Patrick Soon-Shiong in 2014 and is headquartered in San Diego, CA.

ImmunityBio Inc

ImmunityBio is trending as shareholders anxiously await a promised July update amid a period of intense short-selling activity and stock price volatility. The community remains focused on the potential for global partnership announcements and label expansions for Anktiva, while debating the company's long-term commercial trajectory versus its current regulatory and financial hurdles.

iShares Trust - iShares Russell 2000 Index Fund

iShares Russell 2000 ETF

The Russell 2000 is seeing intense community debate as market participants weigh its relative strength against macroeconomic headwinds like geopolitical escalations in the Middle East and cooling inflation data. Traders are actively monitoring small-cap volatility, with many focused on whether current support levels will hold amidst significant uncertainty regarding interest rate policy and broader index rotation.

Venture Global, Inc. engages in the provision of United States liquefied natural gas sourced from resource rich North American natural gas basins. It operates through the following segments: Calcasieu Project, Plaquemines Project, CP2 Project, and Sales and shipping. The company was founded by Michael Sabel and Robert Pender in 2023 and is headquartered in Arlington, VA.

Venture Global Inc. - Ordinary Shares - Class A

Venture Global Inc

Iovance Biotherapeutics, Inc. is a biopharmaceutical company, which engages in the development and commercialization of cell therapies as novel cancer immunotherapy products. Its lead product candidate, LN-144 for metastatic melanoma, is an autologous adoptive cell therapy utilizing tumor-infiltrating lymphocytes (TIL), which are T cells derived from patients' tumors. The company was founded by Robert T. Brooke on September 17, 2007 and is headquartered in San Carlos, CA.

Iovance Biotherapeutics Inc

Iovance Biotherapeutics is surging as investors speculate on potential positive clinical data and M&A activity, fueled by high trading volume and the company's expanding pipeline for solid tumors. The community is actively discussing the stock's potential for institutional accumulation and a possible short squeeze, as shareholders maintain a long-term bullish outlook regarding upcoming regulatory milestones and pipeline developments.

Intuitive Surgical, Inc. engages in the provision of robotic-assisted surgical solutions and invasive care through a comprehensive ecosystem of products and services. Its products include Da Vinci Surgical and Ion Endoluminal systems. The company was founded by Frederic H. Moll, John Gordon Freund, and Robert G. Younge in November 1995 and is headquartered in Sunnyvale, CA.

Intuitive Surgical Inc

Intuitive Surgical (ISRG) is currently facing intense volatility as investors digest a Q2 earnings beat that was overshadowed by a slowdown in U.S. procedure growth and cautious full-year guidance. Despite the stock hitting 52-week lows, the community remains deeply divided, with many long-term holders viewing the pullback as a buying opportunity given the company's dominant market position and cash reserves, while others fear institutional rotation and valuation resets are driving a deeper structural decline.

Sezzle, Inc. engages in the operation of a digital payment platform that enables bank-to-bank transfer of money between consumers and businesses. The company was founded by Charlie G. Youakim, Killian Brackey and Paul V. Paradis on January 4, 2016 and is headquartered in Minneapolis, MN.

Sezzle Inc.

Sezzle is seeing significant community buzz driven by an upcoming earnings report and strong institutional interest, with many investors anticipating a potential short squeeze due to high short interest and a limited float. Shareholders are actively debating the company's long-term growth as a "super app" while holding firm against recent market volatility and analyst downgrades.

Alphabet, Inc. is a holding company, which engages in software, health care, transportation, and other technologies. It operates through the following segments: Google Services, Google Cloud, and Other Bets. The Google Services segment includes products and services, such as ads, Android, Chrome, devices, Google Maps, Google Play, Search, and YouTube. The Google Cloud segment refers to infrastructure and platform services, collaboration tools, and other services for enterprise customers. The Other Bets segment relates to the sale of healthcare-related services and internet services. The company was founded by Lawrence E. Page and Sergey Mikhaylovich Brin on October 2, 2015 and is headquartered in Mountain View, CA.

Alphabet Inc - Ordinary Shares - Class C

Alphabet shares are trending as investors weigh recent reports of development delays for its next-generation Gemini model against its symbolic entry into the Dow Jones Industrial Average. Community sentiment remains sharply divided, with some traders viewing the current volatility as a strategic accumulation opportunity ahead of upcoming earnings, while others remain cautious due to concerns over high AI capital expenditure requirements.

statis crypto Watchlist

Bitcoin

Ethereum

Solana

Ripple

Dogecoin

Cardano

statis IN Watchlist

Nifty 50

Nifty Bank

Reliance Industries Ltd.

Zomato Ltd.

Tata Consultancy Services

Tata Motors Ltd.

HDFC Bank Ltd.

ITC Ltd.

Adani Enterprises Ltd

Axis Bank Ltd

Bajaj Finance Ltd

statis US Watchlist

SPDR S&P 500 ETF

Apple Inc.

Tesla Inc

Microsoft Corporation

NVIDIA Corp

 Hey, I want to invite you to join Stocktwits. It’s the largest global community of active traders. You’ll get access to the real-time market insights, news, discussion and much more! You can sign up using my unique link below 
 


marryclark952

Clark Marry